It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HALO’s FA Score shows that 1 FA rating(s) are green whileNBY’s FA Score has 2 green FA rating(s), and RDUS’s FA Score reflects 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HALO’s TA Score shows that 4 TA indicator(s) are bullish while NBY’s TA Score has 6 bullish TA indicator(s), and RDUS’s TA Score reflects 4 bullish TA indicator(s).
HALO (@Biotechnology) experienced а +2.53% price change this week, while NBY (@Biotechnology) price change was -0.55% , and RDUS (@Steel) price fluctuated 0.00% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +39.21%.
The average weekly price growth across all stocks in the @Steel industry was -0.09%. For the same industry, the average monthly price growth was +3.66%, and the average quarterly price growth was +9.48%.
HALO is expected to report earnings on Nov 10, 2025.
NBY is expected to report earnings on May 15, 2025.
RDUS is expected to report earnings on Oct 23, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Steel (-0.09% weekly)The steel industry includes manufacturers of steel and steel-related products. Companies use iron ore and scrap steel to produce steel. The industry also includes companies involved in mining and marketing of steel products. Along with serving some of the domestic markets, U.S. steel output has, over the years, been used by international economies as well. Competition from imported steel has also increased over time. The industry could be susceptible to business cycles, since the element is an important input in industrial production. Some of the globally-renowned steel behemoths include Nucor Corporation, Vale, and ArcelorMittal SA.
HALO | NBY | RDUS | |
Capitalization | 7.15B | 3.76M | 848M |
EBITDA | 705M | -6.8M | -200.1M |
Gain YTD | 21.334 | 7.454 | 101.533 |
P/E Ratio | 15.43 | 0.03 | N/A |
Revenue | 1.08B | 9.78M | 2.74B |
Total Cash | 748M | 8.47M | 5.44M |
Total Debt | 1.51B | 1.13M | 562M |
HALO | NBY | RDUS | ||
---|---|---|---|---|
OUTLOOK RATING 1..100 | 4 | 5 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 13 Undervalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 36 | 100 | 72 | |
SMR RATING 1..100 | 12 | 13 | 97 | |
PRICE GROWTH RATING 1..100 | 55 | 59 | 37 | |
P/E GROWTH RATING 1..100 | 86 | 36 | 80 | |
SEASONALITY SCORE 1..100 | n/a | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RDUS's Valuation (12) in the Biotechnology industry is in the same range as NBY (13) and is somewhat better than the same rating for HALO (76). This means that RDUS's stock grew similarly to NBY’s and somewhat faster than HALO’s over the last 12 months.
HALO's Profit vs Risk Rating (36) in the Biotechnology industry is somewhat better than the same rating for RDUS (72) and is somewhat better than the same rating for NBY (100). This means that HALO's stock grew somewhat faster than RDUS’s and somewhat faster than NBY’s over the last 12 months.
HALO's SMR Rating (12) in the Biotechnology industry is in the same range as NBY (13) and is significantly better than the same rating for RDUS (97). This means that HALO's stock grew similarly to NBY’s and significantly faster than RDUS’s over the last 12 months.
RDUS's Price Growth Rating (37) in the Biotechnology industry is in the same range as HALO (55) and is in the same range as NBY (59). This means that RDUS's stock grew similarly to HALO’s and similarly to NBY’s over the last 12 months.
NBY's P/E Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for RDUS (80) and is somewhat better than the same rating for HALO (86). This means that NBY's stock grew somewhat faster than RDUS’s and somewhat faster than HALO’s over the last 12 months.
HALO | NBY | RDUS | |
---|---|---|---|
RSI ODDS (%) | 1 day ago63% | 1 day ago90% | 1 day ago68% |
Stochastic ODDS (%) | 1 day ago68% | 1 day ago90% | 1 day ago77% |
Momentum ODDS (%) | 1 day ago72% | 1 day ago86% | 1 day ago70% |
MACD ODDS (%) | N/A | 1 day ago88% | 1 day ago84% |
TrendWeek ODDS (%) | 1 day ago75% | 1 day ago90% | 1 day ago74% |
TrendMonth ODDS (%) | 1 day ago74% | 1 day ago83% | 1 day ago70% |
Advances ODDS (%) | 7 days ago77% | 6 days ago82% | 8 days ago74% |
Declines ODDS (%) | 17 days ago68% | 1 day ago90% | 22 days ago80% |
BollingerBands ODDS (%) | 1 day ago60% | 1 day ago90% | 1 day ago75% |
Aroon ODDS (%) | 1 day ago63% | 1 day ago88% | 1 day ago60% |